Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion

Trial Profile

Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jun 2015

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Retinal oedema; Retinal vein occlusion
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 21 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top